These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

721 related items for PubMed ID: 31463807

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Cancer Risk and Surveillance in Primary Sclerosing Cholangitis.
    Folseraas T, Boberg KM.
    Clin Liver Dis; 2016 Feb; 20(1):79-98. PubMed ID: 26593292
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma.
    Chung BK, Karlsen TH, Folseraas T.
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1390-1400. PubMed ID: 28844951
    [Abstract] [Full Text] [Related]

  • 27. Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation.
    Boberg KM, Bergquist A, Mitchell S, Pares A, Rosina F, Broomé U, Chapman R, Fausa O, Egeland T, Rocca G, Schrumpf E.
    Scand J Gastroenterol; 2002 Oct; 37(10):1205-11. PubMed ID: 12408527
    [Abstract] [Full Text] [Related]

  • 28. Hepatobiliary and extra-hepatic malignancies in primary sclerosing cholangitis.
    Bergquist A, Broomé U.
    Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):643-56. PubMed ID: 11492973
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis.
    Villard C, Friis-Liby I, Rorsman F, Said K, Warnqvist A, Cornillet M, Kechagias S, Nyhlin N, Werner M, Janczewska I, Hagström T, Nilsson E, Bergquist A.
    J Hepatol; 2023 Mar; 78(3):604-613. PubMed ID: 36410555
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Recall processes for biliary cytology in primary sclerosing cholangitis.
    Eaton JE, Gossard AA, Talwalkar JA.
    Curr Opin Gastroenterol; 2014 May; 30(3):287-94. PubMed ID: 24686433
    [Abstract] [Full Text] [Related]

  • 37. Diagnosis, Differential Diagnosis, and Epidemiology of Primary Sclerosing Cholangitis.
    Ponsioen CY.
    Dig Dis; 2015 May; 33 Suppl 2():134-9. PubMed ID: 26640943
    [Abstract] [Full Text] [Related]

  • 38. Screening for malignancy in primary sclerosing cholangitis (PSC).
    Khaderi SA, Sussman NL.
    Curr Gastroenterol Rep; 2015 Apr; 17(4):17. PubMed ID: 25786901
    [Abstract] [Full Text] [Related]

  • 39. Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms.
    Melum E, Karlsen TH, Schrumpf E, Bergquist A, Thorsby E, Boberg KM, Lie BA.
    Hepatology; 2008 Jan; 47(1):90-6. PubMed ID: 18023027
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 37.